Main
Sir,
Patients with neurofibromatosis type 2 (NF-2), a rare autosomal dominant disease caused by mutations in the NF-2 tumour-suppressor gene on chromosome 22q12,1 are predisposed to central nervous system tumours. Paediatric presentation is not yet well defined and differs from adult onset as the diagnostic criteria2 are often not met at initial clinical manifestation.3
This report describes a boy with a trigeminal and a plexiform schwannoma and juvenile cataract without bilateral vestibular schwannomas and lacking a positive family history, who was diagnosed with NF-2.
Case report
A 10-year-old boy was referred by the paediatric ward with a 3-week history of recurrent vomiting, lack of appetite, weight loss, frontal headaches, and inattentiveness at school. Psychiatric assessment indicated an onset of anorexia/bulimia with functional headaches possibly due to social and school problems.
Pre-existing diagnoses were posterior subcapsular lens opacity in the right eye (Figure 1) with amblyopia, esotropia, and dissociated vertical divergence. Strabismus surgery had been performed at 7 years of age. Ocular motility had not been restricted. A plexiform schwannoma of the thorax had also been excised.
On ophthalmologic examination, visual acuity measured 20/50 in the right and 20/25 in the left eye. Ocular motility testing showed extensive limitation of right abduction. Sensory function of the right trigeminal nerve was markedly diminished.
At 2 weeks after a CT scan of the head—that notably had been reported as unremarkable—a subsequent MRI detected an extraaxial mass at the right petrous apex extending forward into Meckel's cave and the cavernous sinus (Figure 2). This tumour had originated from the right trigeminal nerve and was subtotally removed in a one-stage procedure. Histological examination confirmed the diagnosis of schwannoma. Concurrence of juvenile cataract and schwannomas led to the suspicion of NF-2. Genetic testing revealed a nonsense-mutation of the NF-2 gene.
Comment
Further refinement of the diagnostic systems2 for NF-2 in both children and adults is of great importance for early detection of this debilitating disease. NF-2 should be included in the differential diagnosis in patients with isolated schwannomas comprising a close look for further features typical of NF-2 and the use of genetic testing as a diagnostic tool.
References
Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363(6429): 515–521.
Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG . Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 2002; 59(11): 1759–1765.
Evans DG, Birch JM, Ramsden RT . Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 1999; 81(6): 496–499.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bosch, M., Mironov, A. & Killer, H. Atypical manifestation of neurofibromatosis type 2 in a boy. Eye 19, 705–706 (2005). https://doi.org/10.1038/sj.eye.6701603
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.eye.6701603